Cyril Amarchand Mangaldas has a focused life sciences and healthcare practice, handling corporate and private equity deals across the space, as well as providing advice on existing and upcoming regulations and legislation, and representing clients in high-stakes litigation, including major product liability cases in the medical devices sector. The team advises major domestic healthcare providers, life sciences and pharma producers, and international investors, with standout expertise in global de-mergers on the transactional side. Ashwin Sapra leads the team, advising on intellectual property, regulatory, and transactional matters, while Biplab Lenin is particularly active in the digital health space, advising on a number of major investments. Senior associate Kartik Jain is also a key name in the Noida-based team, advising on strategic regulatory compliance issues as well as regulatory elements of M&A and private equity deals.

Legal 500 Editorial commentary

Key clients

  • Suven Pharmaceuticals Limited
  • Gland Pharma Limited
  • Bessemer Venture Partners Trust
  • International Finance Corporation(IFC)
  • Plus Health Tech Ventures Private Limited (Ayu Health)
  • Enzene Biosciences Limited

Lawyers

Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Practice head

The lawyer(s) leading their teams.

Ashwin Sapra

Other key lawyers

Biplab Lenin, Kartik Jain